Literature DB >> 26254373

A Case of Focal Small-cell Neuroendocrine Carcinoma in the Vicinity of the Extrahepatic Bile Duct, Adjacent to an Extensive Biliary Intraepithelial Neoplasm: A Diagnostic Challenge with Major Clinical Implications.

Birgit Aigner1, Peter Kornprat2, Helmut Schöllnast3, Anne-Katrin Kasparek4, Hans-Jörg Mischinger2, Johannes Haybaeck5.   

Abstract

Gastroenteropancreatic neuroendocrine tumors are known for their aggressiveness. Diagnosis of various bile duct pathologies, like biliar intraepithelial neoplasm, mixed adenoneuroendocrine carcinomas or small cell carcinomas, is challenging. This case report focuses on a rare case of a focal primary minute small cell carcinoma in the vicinity of the extrahepatic bile duct, presenting itself next to an extensive biliar intraepithelial neoplasm. This finding led to adjuvant chemotherapy, followed by major surgery. Therapeutic approach was based on CT and MRI scans but most importantly on immunohistochemistry and histological evaluation. Initially CR seemed achievable, but metastases were to be found rapidly. The authors want to underline the fact that major clinical decisions are based on sometimes tiny specimens; as literature shows it is absolutely advisable to use markers to differentiate the dignity of investigated areas. The authors call for keeping collision of tumors in mind and adding KOC staining and using it in a routine manner examining biliary duct lesions. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Neuroendocrine carcinoma; biliary intraepithelial neoplasia; chemotherapy; extrahepatic bile duct

Mesh:

Year:  2015        PMID: 26254373

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Neuroendocrine tumor of the common bile duct: a case report and review of the literature.

Authors:  Zhong Liu; Deng-Yong Zhang; Zheng Lu; Pei Zhang; Wan-Liang Sun; Xiang Ma; Hua Wu; Bin-Quan Wu; Shuo Zhou
Journal:  Onco Targets Ther       Date:  2018-04-23       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.